Drugmakers brace for a pricing fight as Xavier Becerra is confirmed as the next HHS secretary
By a razor-thin margin of 50-49, all Senate Democrats and Maine Republican Susan Collins on Thursday confirmed former California Attorney General Xavier Becerra as the head of the Department of Health and Human Services (HHS) — setting the stage for what may be major pricing battles with the biopharma industry.
The partisan divide over Becerra’s nomination came as Democrats lined up behind Becerra’s tough stance against drugmakers and for Obamacare, among other issues, while Republicans lambasted his lack of medical and scientific experience, as well as his tough stance against the pharmaceutical industry.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.